Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1619 1763
This examiner grants 0% of resolved cases
Matthew Ryan Burke is an examiner in Tech Center 1700 and Art Unit 1619. His profile is based on 1 resolved cases, which show an allowance rate pct of 0.0. This indicates that the single case resolved did not result in a patent grant. The median days to allowance is 917, though this figure is based on a limited set of outcomes from filing to grant.
The interview lift pct of 0.0 suggests that interviews have not changed the outcome of the cases processed so far. Because the allowance rate pct is 0.0, there is no record of an interview leading to a grant in this sample. Practitioners in Art Unit 1619 should focus on the 917 median days to allowance as the only available timing metric for the 1 resolved cases. This lift is a neutral factor.
With only 1 resolved cases, the examiner's metrics are sensitive to future outcomes. The 0.0 allowance rate pct and the 917 median days to allowance define the current data set. As more cases are resolved, the 0.0 interview lift pct may change, but for now, the path to a grant remains unproven in Tech Center 1700. The 917 median days to allowance is the primary timing guide.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18805889 | HAIR CARE COMPOSITION | Final Rejection | The Procter & Gamble Company |
| 18581755 | ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING CAPSULES | Non-Final OA | The Procter & Gamble Company |
| 18840308 | AMPHOTERIC ALKYLAMIDO BETAINES PRODUCED FROM MACAÚBA PALM OIL | Final Rejection | BASF SE |
| 18839330 | HERBICIDAL QUINOLONE DERIVATIVES | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18797678 | OXIDATIVE HAIR TREATMENT AGENT WITH A CONTROLLED HEAT DEVELOPMENT BASED ON ENVIRONMENTALLY FRIENDLY CONTENTS | Non-Final OA | Henkel AG & Co. KGaA |
| 18741918 | COLOR RETENTION SYSTEMS USING DENDRIMER AND CHITOSAN COMPLEX FOR LONG-LASTING EFFECT | Final Rejection | Henkel AG & Co. KGaA |
| 18840401 | Functionalized Nanoclusters and Their Use in Treating Bacterial Infections | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18833637 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Non-Final OA | Purdue Research Foundation |
| 18544223 | OIL-IN-WATER DISPERSION COMPRISING HYDROPHOBIC POLYMER AND BIOSURFACTANT | Final Rejection | L'OREAL |
| 18621369 | PERSONAL CARE COMPOSITIONS | Final Rejection | COLGATE-PALMOLIVE COMPANY |
| 18849428 | BIODEGRADABLE CONTROLLED RELEASE ANTIVIRAL AGENT IMPLANTS | Non-Final OA | Yale University |
| 18833758 | COSMETIC PRODUCT COMPRISING A FLEXIBLE CONTAINER AND AN AQUEOUS OXIDATIVE COMPOSITION CONTAINED THEREIN | Non-Final OA | KAO CORPORATION |
| 18770080 | DEODORANT FRAGRANCE COMPOSITION | Non-Final OA | TAKASAGO INTERNATIONAL CORPORATION |
| 18746938 | FLUSHABLE WET WIPES | Non-Final OA | The University of Toledo |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy